Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Molecular markers of early pancreatic cancer.

Goggins M.

J Clin Oncol. 2005 Jul 10;23(20):4524-31. Review.

PMID:
16002843
2.
3.

Caveolin-1: a marker for pancreatic cancer diagnosis.

Tanase CP.

Expert Rev Mol Diagn. 2008 Jul;8(4):395-404. doi: 10.1586/14737159.8.4.395. Review.

PMID:
18598222
4.

Identifying molecular markers for the early detection of pancreatic neoplasia.

Goggins M.

Semin Oncol. 2007 Aug;34(4):303-10. Review. Erratum in: Semin Oncol. 2012 Dec;39(6):716.

5.

DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.

Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, Yeo CJ, Kalloo A, Hruban R, Goggins M.

Cancer Res. 2006 Jan 15;66(2):1208-17.

6.

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J.

Clin Chem. 2010 Jul;56(7):1107-18. doi: 10.1373/clinchem.2010.144709. Epub 2010 Apr 29.

7.

[The S3 guideline exocrine pancreatic cancer].

Seufferlein T, Adler G.

Med Klin (Munich). 2009 Nov 15;104(11):869-74. doi: 10.1007/s00063-009-1183-7. German.

PMID:
19916076
8.

Molecular prognostic factors in patients with pancreatic cancer.

Tonini G, Pantano F, Vincenzi B, Gabbrielli A, Coppola R, Santini D.

Expert Opin Ther Targets. 2007 Dec;11(12):1553-69. Review.

PMID:
18020978
9.

PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.

Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH.

Clin Cancer Res. 2007 Dec 15;13(24):7380-7.

10.

Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.

Dittert DD, Kielisch C, Alldinger I, Zietz C, Meyer W, Dobrowolski F, Saeger HD, Baretton GB.

Hum Pathol. 2008 Jul;39(7):1002-10. doi: 10.1016/j.humpath.2007.11.016. Epub 2008 May 20.

PMID:
18495213
11.

Genetic alterations in precancerous pancreatic lesions and their clinical implications.

Turrini O, Cano C, Legoffic A, Delpero JR, Dagorn JC, Iovanna J.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):1028-35, e1-9. doi: 10.1016/j.gcb.2009.08.007. Epub 2009 Sep 18. English, French.

12.

Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma.

Szafranska-Schwarzbach AE, Adai AT, Lee LS, Conwell DL, Andruss BF.

Expert Rev Mol Diagn. 2011 Apr;11(3):249-57. doi: 10.1586/erm.11.10.

PMID:
21463235
13.

Midkine mRNA is overexpressed in pancreatic cancer.

Ohhashi S, Ohuchida K, Mizumoto K, Egami T, Yu J, Cui L, Toma H, Takahata S, Nabae T, Tanaka M.

Dig Dis Sci. 2009 Apr;54(4):811-5. doi: 10.1007/s10620-008-0434-4. Epub 2008 Aug 21.

PMID:
18712601
14.

Detecting and diagnosing ampullary neoplasms.

Wang LF, Hingorani SR, Tuveson DA.

Cancer Biol Ther. 2004 Jul;3(7):657-9. Epub 2004 Jul 20. No abstract available.

PMID:
15326385
15.

LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.

Nakata K, Ohuchida K, Nagai E, Hayashi A, Miyasaka Y, Kayashima T, Yu J, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.

Neoplasia. 2009 Jul;11(7):712-9.

16.

Current status of gene expression profiling of pancreatic cancer.

Goonetilleke KS, Siriwardena AK.

Int J Surg. 2008 Feb;6(1):81-3. doi: 10.1016/j.ijsu.2006.09.001. Epub 2006 Oct 27. Review.

17.

Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.

Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1648-52. doi: 10.1158/1055-9965.EPI-07-2791.

18.

Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.

Funel N, Giovannetti E, Pollina LE, del Chiaro M, Mosca F, Boggi U, Campani D.

Expert Rev Mol Diagn. 2011 Sep;11(7):695-701. doi: 10.1586/erm.11.62. Review.

PMID:
21902531
19.

Pancreatic cancer: a plea for good and comprehensive morphological studies.

Alg├╝l H, Schmid RM.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):713-5. doi: 10.1097/MEG.0b013e3282f9460e. Review.

PMID:
18617774
20.

Early detection markers in Pancreas Cancer.

Farrell JJ, van Rijnsoever M, Elsaleh H.

Cancer Biomark. 2005;1(2-3):157-75. Review.

PMID:
17192037

Supplemental Content

Support Center